Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial

BACKGROUND: Remifentanil is widely used for ultrasound-guided percutaneous radiofrequency ablation (RFA) of small hepatocellular carcinoma (HCC). We determined whether dexmedetomidine could be an alternative to remifentanil for RFA of HCC under general anesthesia with sevoflurane. METHODS: We prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jingru, Li, Xianlong, He, Ye, Jian, Chaojun, Chen, Hui-xin, Hei, Ziqing, Zhou, Shaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326039/
https://www.ncbi.nlm.nih.gov/pubmed/30621749
http://dx.doi.org/10.1186/s13063-018-3010-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326039/
https://www.ncbi.nlm.nih.gov/pubmed/30621749
http://dx.doi.org/10.1186/s13063-018-3010-z

Ejemplares similares